Defence Therapeutics Inc
OTC:DTCFF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Defence Therapeutics Inc
OTC:DTCFF
|
CA |
|
V
|
Vale Indonesia Tbk PT
XMUN:XT3B
|
ID |
|
E
|
Everest Global PLC
LSE:EVST
|
UK |
|
Forbo Holding AG
SIX:FORN
|
CH |
|
U
|
Unirea Shopping Center SA
XBSE:SCDM
|
RO |
|
Photocure ASA
F:PHS
|
NO |
|
B
|
Bayer AG
BET:BAYER
|
DE |
|
Optimus Group Co Ltd
OTC:OPTGF
|
JP |
|
Alantra Partners SA
F:DNY
|
ES |
|
L
|
Launch One Acquisition Corp
NASDAQ:LPAA
|
US |
|
Excite Technology Services Ltd
ASX:EXT
|
AU |
Shareholder Yield
Current shareholder yield for DTCFF is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DTCFF Price
Defence Therapeutics Inc
| Average Annual Return | -28.99% |
| Standard Deviation of Annual Returns | 48.55% |
| Max Drawdown | -95% |
| Market Capitalization | 21.8m USD |
| Shares Outstanding | 45 536 700 |
| Percentage of Shares Shorted |
N/A
|
